- Home
- NMRA vs KFS Comparison
NMRA vs KFS Comparison
Compare NMRA & KFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | NMRA | KFS |
|---|---|---|
| Founded | 2019 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Property-Casualty Insurers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.4M | 352.8M |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | NMRA | KFS |
|---|---|---|
| Price | $2.11 | $13.31 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 99.4K |
| Earning Date | 03-02-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $128,567,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.31 |
| 52 Week Low | $0.61 | $7.06 |
| 52 Week High | $3.25 | $16.80 |
Technical Indicators
Market Signals| Indicator | NMRA | KFS |
|---|---|---|
| Relative Strength Index (RSI) | 53.06 | 54.17 |
| Support Level | $1.84 | $13.04 |
| Resistance Level | $2.20 | $13.75 |
| Average True Range (ATR) | 0.25 | 0.77 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 56.54 | 81.60 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.